Takeda’s 1st Half Operating Profits Down 48% due to M&A Costs

Takeda Pharmaceutical said on October 31 that its operating profits on a consolidated basis for April-September, the first half of FY2012, sank 48.6% from a year earlier to 108,576 million yen due to an increase in costs linked to the...read more